Sitka Biopharma
focuses on developing a nanoparticle platform to increase drug absorption of difficult-to-penetrate tissues in cancer treatments... Read moreSitka Biopharma
focuses on developing a nanoparticle platform to increase drug absorption of difficult-to-penetrate tissues in cancer treatments... Read more
News
Feb 11, 2019
BioSpace
Sitka Biopharma: CDRD Invests in Sitka Biopharma to Advance Bladder Cancer Treatment to Clinical Trial
Feb 11, 2019
Sitka Blog
Sitka Blog CDRD Invests in Sitka Biopharma to Advance Bladder Cancer Treatment to Clinical Trial
Oct 25, 2018
PE Hub Network
Sitka Biopharma: Sitka Biopharma nets $1.9 mln
Oct 25, 2018
Sitka Blog
Sitka Blog Sitka Biopharma Announces New Investment from Global Health Sciences Fund
Aug 07, 2017
Sitka Blog
Sitka Blog Quark Venture releases final tranche of funding
Jun 27, 2017
BioPortfolio
Sitka Biopharma: UK trial for new bladder cancer therapy
Jun 27, 2017
Drug Development Technology
Sitka Biopharma:
Sitka Biopharma to initiate Phase I trial of STK-01 to treat bladder cancer
Jun 26, 2017
Sitka Blog
Sitka Blog New Bladder Cancer Therapy to Start Clinical Trials
Mar 06, 2017
Sitka Blog
Sitka Blog Sitka Biopharma is Ready to Rocket!
Apr 21, 2016
PE Hub Network
Sitka Biopharma: CDRD-UBC spin-off Sitka Biopharma seeded by Quark Venture
Sitka Biopharma Competitors
1
2
3
4
5
6
7
8
9
10